Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01273389
What this trial is testing

An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 25
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Post-approval studies (Phase 4)Looking for participantsNCT07746895
What this trial is testing

Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study

Who this might be right for
C3 Glomerulopathy (C3G)Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Swedish Orphan Biovitrum 150
Not applicableStudy completedNCT00876616
What this trial is testing

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Zhi-Hong Liu, M.D. 362
Testing effectiveness (Phase 2)Study completedNCT03832114
What this trial is testing

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

Who this might be right for
Glomerulonephritis
Novartis Pharmaceuticals 27
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Large-scale testing (Phase 3)UnknownNCT03942887
What this trial is testing

Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis
Leiden University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT03610516
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT06786338
What this trial is testing

SGB-9768 in Patients With Complement-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)C3 GlomerulopathyIC-MPGN
Suzhou Sanegene Bio Inc. 45
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Not applicableEnded earlyNCT02294344
What this trial is testing

The Clinical Efficacy of DFPP in Patients With AAGN

Who this might be right for
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Zhi-Hong Liu, M.D. 14
Testing effectiveness (Phase 2)Looking for participantsNCT07375758
What this trial is testing

MIL116 in Healthy Participants and Patients With IgA Nephropathy.

Who this might be right for
Immunoglobulin A Nephropathy
Beijing Mabworks Biotech Co., Ltd. 130
Post-approval studies (Phase 4)Looking for participantsNCT07225387
What this trial is testing

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

Who this might be right for
Lupus Nephritis
NephroNet, Inc. 30
Early research (Phase 1)Study completedNCT06004947
What this trial is testing

A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Who this might be right for
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Amgen 32
Testing effectiveness (Phase 2)Study completedNCT00050713
What this trial is testing

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

Who this might be right for
Membranous GlomerulonephritisLupus Membranous Nepropathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Post-approval studies (Phase 4)Looking for participantsNCT07760480
What this trial is testing

Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus (SLE)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 55
Not applicableLooking for participantsNCT02954939
What this trial is testing

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 50
Early research (Phase 1)WithdrawnNCT00583427
What this trial is testing

Sulodexide Treatment in Patients With Dense Deposit Disease

Who this might be right for
Dense Deposit Disease
University of Iowa
Testing effectiveness (Phase 2)Ended earlyNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Not applicableUnknownNCT05797038
What this trial is testing

Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC

Who this might be right for
Idiopathic Membranous NephropathyTacrolimusHyperspectral Imaging
Qianfoshan Hospital 40
Next Page